The canine urolithiasis treatment market is projected to grow from USD 2.4 billion in 2026 to USD 4.3 billion by 2036, at a CAGR of 6.0%. Prescription diets will dominate with a 38.0% market share, while struvite stones will lead the applications segment with a 42.0% share.